로딩 중…
지수 로딩 중…
Telix Pharmaceuticals Limited
TLX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
AU
AU$10.09+1.51%
2026-06-18
Price Chart
Telix Pharmaceuticals Limited-40.51%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $3.42B |
| Revenue | $778M |
| Net Income | $-7M |
| Total Assets | $1.18B |
| Net Assets | $415M |
| Value | |
| P/B | 8.23x |
| P/S | 4.39x |
| EV/EBITDA | 73.74x |
| FCF Yield | -1.56% |
| Profitability | |
| ROE | -1.66% |
| ROA | -0.58% |
| Op. Margin | 2.21% |
| Revenue Growth | 53.91% |
| Earnings Growth | -121.41% |
| Financial Health | |
| Debt Ratio | 184.59% |
| Total Debt | $523M |
| FCF | $-53M |
| Cash | $142M |
| Current Ratio | 1.43x |
| Net Debt/EBITDA | 7.41x |
| Performance | |
| 1Y Return | -40.51% |
| 1M Return | -0.79% |
| From 52W High | -40.58% |
| 1Y MDD | -66.65% |
| Trading | |
| Volume | 77,071 shares |
| Trading Value | $776104.00 |
| Per Share | |
| EPS | $0.07 |
| BPS | $1.15 |